RCEL
AVITA Medical (RCEL)
$75
About AVITA Medical (RCEL)
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Details
Daily high
$4.84
Daily low
$4.48
Price at open
--
52 Week High
$7.12
52 Week Low
$3.22
Market cap
111.0M
Dividend yield
0.00%
Volume
54
Avg. volume
230,428
P/E ratio
-2.85
AVITA Medical News
Details
Daily high
$4.84
Daily low
$4.48
Price at open
--
52 Week High
$7.12
52 Week Low
$3.22
Market cap
111.0M
Dividend yield
0.00%
Volume
54
Avg. volume
230,428
P/E ratio
-2.85